Back to Search
Start Over
A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer.
- Source :
- Radiation Oncology; 9/2/2019, Vol. 14 Issue 1, pN.PAG-N.PAG, 1p
- Publication Year :
- 2019
-
Abstract
- <bold>Purpose: </bold>To report results from our phase I dose-escalation study of stereotactic body radiotherapy (SBRT) using 4 fractions for patients with localized prostate cancer.<bold>Materials& Methods: </bold>Fraction sizes of 8 Gy, 8.5 Gy, and 9 Gy were defined as levels 1, 2, and 3. The prescribed dose was delivered to at least 95% of the planning target volume. Image-guided, intensity-modulated radiotherapy was delivered to all patients. Dose-limiting toxicity (DLT) was defined as acute toxicity of Grade 3 or higher. The maximum tolerated dose (MTD) was defined as the level at which ≥30% of patients showed DLT. The recommended dose (RD) was defined to be one dose level below the MTD. If no patients at level 3 showed DLT, level 3 was defined as the recommended dose (RD).<bold>Results: </bold>Nine patients were enrolled in each level. All patients were low or intermediate risk. Median durations of follow-up for patients at levels 1-3 were 48.9 months, 42.6 months, and 18.4 months, respectively. Protocol treatment was completed for all patients. No patient showed DLT at each dose level. Level 3 was therefore designated as the RD for the phase II study. Although most toxicities were Grade 1, genitourinary toxicity was common compared to gastrointestinal toxicity. Three-year biochemical control rate was 90.3%.<bold>Conclusion: </bold>The dose level of 36 Gy in 4 fractions with a 2-day break was tolerable and highly encouraging for SBRT of localized prostate cancer. The phase II trial to confirm the efficacy and toxicity of this treatment is now on going.<bold>Trial Registration: </bold>UMIN, UMIN000010236 . Registered 13 March 2013. [ABSTRACT FROM AUTHOR]
- Subjects :
- STEREOTACTIC radiotherapy
PROSTATE cancer patients
INTENSITY modulated radiotherapy
FRACTIONS
ADENOCARCINOMA
HUMAN body
CLINICAL trials
COMPARATIVE studies
DRUG dosage
DRUG toxicity
RESEARCH methodology
MEDICAL cooperation
COMPUTERS in medicine
PROGNOSIS
PROSTATE tumors
RADIATION doses
RADIOSURGERY
RADIOTHERAPY
RESEARCH
EVALUATION research
Subjects
Details
- Language :
- English
- ISSN :
- 1748717X
- Volume :
- 14
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Radiation Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 138394991
- Full Text :
- https://doi.org/10.1186/s13014-019-1369-y